Mohammed H. Al-Qahtani, Mohammad Alam Jafri, Mourad Assidi, Abdelbaset Buhmeida, Peter Natesan Pushparaj, Maha Khalid Abdullah, Nofe Ateq Alganmi. "Multitargeted comparative evaluation suggests 2-Aoeobenoxmide shows favourable in silico binding compared to Tucatinib against ERα, HER2, AKT1, EGFR, and PIK3CA in breast cancer." Scientific Reports, 2026. doi:10.1038/s41598-026-57604-0